相关实验视频

Updated: Jun 24, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

准备和初步评估的小说68Ga标记线性PET探测器向nectin-4的初步评估

Deng Ke Li^1,2, Xue Cen Cao^1,2, Chao Mu^1,2

¹Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China.

Cancer biotherapy & radiopharmaceuticals

|November 5, 2025

概括

一种新的线性酸正子发射断层扫描 (PET) 探针,[68Ga]Ga-NOTA-SP,有效地准Nectin-4用于快速瘤成像. 这种新的探测器显示了改善Nectin-4相关癌症诊断和治疗的前景.

科学领域:

核医学是一种核医学.
放射化学放射化学是指辐射化学.
分子成像学分子成像学

背景情况:

尼克-4是癌症治疗的验证标.
现有的Nectin-4正子发射断层扫描 (PET) 探针需要改进生产和药物动力学特征.

研究的目的:

开发一种新的线性皮质PET探针,以高效成像Nectin-4表达瘤.
评估这种新型探针对与Nectin-4相关的癌症的诊断潜力.

主要方法:

使用放射化学技术合成[68Ga]Ga-NOTA-SP并进行质量控制.
分子对接以预测Nectin-4的结合亲和力.
在SW780瘤模型中的体外细胞实验和体内PET/CT成像.
在正常小鼠中的药理动力学分析.

主要成果:

[68Ga]Ga-NOTA-SP实现了高标签效率 (>95%) 和体外稳定性.
分子对接和细胞研究证实了Nectin-4的高特异性和结合亲和力 (Kd = 2.483 nM).
在体内,PET/CT成像显示成功准Nectin-4阳性瘤.

结论:

[68Ga]Ga-NOTA-SP表现出有利的药理动力学和特定的Nectin-4向.
这种线性探头能够快速成像Nectin-4相关的瘤.
它代表了优化诊断和治疗Nectin-4驱动癌症的有希望的工具.

关键词:

68GaGa 68GaGaGa 68GaGa 68GaGa 68GaGa 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 68Ga 尼克-4的使用方法在这里,PET是PET.这是一种线性.

更多相关视频

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET